Funded Biotech startups in North Carolina
7 biotech startups in North Carolina have filed a Form D with the SEC and together report $31.7M raised. Xilis has the largest latest round, at $19.4M. Amounts are as reported on the filing, not estimates.
Updated Dec 22, 2025
- Companies
- 7
- Total raised
- $31.7M
- Filings
- 8
- Median round
- $1.9M
- Cities
- 5
CompanyCityLast filingLatest round
Adaptin BIOBrain-penetrating T cell therapy for glioblastoma
Charlotte
Dec 22, 2025
$1.9M
PIPr TherapeuticsPreclinical metalloprotease inhibitor drugs
Durham
Oct 31, 2025
$1.5M
XilisMiniature tumor models that match patients to cancer drugs
Durham
Apr 10, 2025
$19.4M
Altis BiosystemsHuman gut tissue models for drug testing
Durham
Mar 31, 2025
$2.1M
ScorpiusContract biologics development and manufacturing
Morrisville
Jan 30, 2025
$600K
Aer TherapeuticsInhaled drug that dissolves airway mucus plugs
Raleigh
Jan 24, 2025
$5.0M
BioPhoundryPioneering biotechnology company that specializes in the…
Chapel Hill
Dec 10, 2024
$1.1M
All 7 companies · most recent filing first
Most recent filings
7All 7 companies · most recent filing first